Hepatology (original) (raw)
Home > October 2017 - Volume 66 - Issue 4
Issue Information
Masthead
Hepatology. 66(4):n/a, October 2017.
Notices
Hepatology. 66(4):n/a, October 2017.
Hepatology Highlights
Hepatology Highlights
Russo, Nicholas; Brown, Robert S. Jr.; Schwartz, Robert E.; More
Russo, Nicholas; Brown, Robert S. Jr.; Schwartz, Robert E.; Rosenblatt, Russell; Cohen‐Mekelburg, Shirley; Saumoy, Monica; Tow, Clara; Schneider, Yecheskel; Gupta, Vikas Less
Hepatology. 66(4):1013-1015, October 2017.
Message from the President
Comments on cochrane review on direct‐acting antivirals for hepatitis C
Lok, Anna S.; Chung, Raymond T.; Vargas, Hugo E.; More
Lok, Anna S.; Chung, Raymond T.; Vargas, Hugo E.; Kim, Arthur Y.; Naggie, Susanna; Powderly, William G. Less
Hepatology. 66(4):1016-1019, October 2017.
Comments from the Editors
Editorials
Original Articles
Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years
Fung, James; Wong, Tiffany; Chok, Kenneth; More
Fung, James; Wong, Tiffany; Chok, Kenneth; Chan, Albert Chi-Yan; Cheung, Tan‐To; Dai, Jeff Wing‐Chiu; Sin, Sui‐ling; Ma, Ka‐Wing; Ng, Kelvin; Ng, Kevin Tak‐Pan; Seto, Wai‐Kay; Lai, Ching‐Lung; Yuen, Man‐Fung; Lo, Chung‐Mau Less
Hepatology. 66(4):1036-1044, October 2017.
A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha
Cao, Zhenhuan; Liu, Yali; Ma, Lina; More
Cao, Zhenhuan; Liu, Yali; Ma, Lina; Lu, Junfeng; Jin, Yi; Ren, Shan; He, Zhimin; Shen, Chengli; Chen, Xinyue Less
Hepatology. 66(4):1058-1066, October 2017.
Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice
Bian, Yingjie; Zhang, Zheng; Sun, Zhichen; More
Bian, Yingjie; Zhang, Zheng; Sun, Zhichen; Zhao, Juanjuan; Zhu, Danming; Wang, Yang; Fu, Sherry; Guo, Jingya; Liu, Longchao; Su, Lishan; Wang, Fu‐Sheng; Fu, Yang‐Xin; Peng, Hua Less
Hepatology. 66(4):1067-1082, October 2017.
Sofosbuvir‐velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct‐acting antiviral regimen
Gane, Edward J.; Shiffman, Mitchell L.; Etzkorn, Kyle; More
Gane, Edward J.; Shiffman, Mitchell L.; Etzkorn, Kyle; Morelli, Giuseppe; Stedman, Catherine A.M.; Davis, Mitchell N.; Hinestrosa, Federico; Dvory‐Sobol, Hadas; Huang, K.C.; Osinusi, Anu; McNally, John; Brainard, Diana M.; McHutchison, John G.; Thompson, Alex J.; Sulkowski, Mark S.; GS‐US‐342‐1553 Investigators Less
Hepatology. 66(4):1083-1089, October 2017.
Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study
Saxena, Varun; Khungar, Vandana; Verna, Elizabeth C.; More
Saxena, Varun; Khungar, Vandana; Verna, Elizabeth C.; Levitsky, Josh; Brown, Robert S. Jr; Hassan, Mohamed A.; Sulkowski, Mark S.; O'Leary, Jacqueline G.; Koraishy, Farrukh; Galati, Joseph S.; Kuo, Alexander A.; Vainorius, Monika; Akushevich, Lucy; Nelson, David R.; Fried, Michael W.; Terrault, Norah; Reddy, K. Rajender Less
Hepatology. 66(4):1090-1101, October 2017.
Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection
Wirth, Stefan; Rosenthal, Philip; Gonzalez‐Peralta, Regino P.; More
Wirth, Stefan; Rosenthal, Philip; Gonzalez‐Peralta, Regino P.; Jonas, Maureen M.; Balistreri, William F.; Lin, Chuan‐Hao; Hardikar, Winita; Kersey, Kathryn; Massetto, Benedetta; Kanwar, Bittoo; Brainard, Diana M.; Shao, Jiang; Svarovskaia, Evguenia; Kirby, Brian; Arnon, Ronen; Murray, Karen F.; Schwarz, Kathleen B. Less
Hepatology. 66(4):1102-1110, October 2017.
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Arbelaiz, Ander; Azkargorta, Mikel; Krawczyk, Marcin; More
Arbelaiz, Ander; Azkargorta, Mikel; Krawczyk, Marcin; Santos‐Laso, Alvaro; Lapitz, Ainhoa; Perugorria, Maria J.; Erice, Oihane; Gonzalez, Esperanza; Jimenez‐Agüero, Raul; Lacasta, Adelaida; Ibarra, Cesar; Sanchez‐Campos, Alberto; Jimeno, Juan P.; Lammert, Frank; Milkiewicz, Piotr; Marzioni, Marco; Macias, Rocio I.R.; Marin, Jose J.G.; Patel, Tushar; Gores, Gregory J.; Martinez, Ibon; Elortza, Félix; Falcon‐Perez, Juan M.; Bujanda, Luis; Banales, Jesus M. Less
Hepatology. 66(4):1125-1143, October 2017.
aPKC‐ι/P‐Sp1/Snail signaling induces epithelial–mesenchymal transition and immunosuppression in cholangiocarcinoma
Qian, Yawei; Yao, Wei; Yang, Tao; More
Qian, Yawei; Yao, Wei; Yang, Tao; Yang, Yan; Liu, Yan; Shen, Qi; Zhang, Jian; Qi, Weipeng; Wang, Jianming Less
Hepatology. 66(4):1165-1182, October 2017.
H19 promotes cholestatic liver fibrosis by preventing ZEB1‐mediated inhibition of epithelial cell adhesion molecule
Song, Yongfeng; Liu, Chune; Liu, Xia; More
Song, Yongfeng; Liu, Chune; Liu, Xia; Trottier, Jocelyn; Beaudoin, Michele; Zhang, Li; Pope, Chad; Peng, Guangyong; Barbier, Olivier; Zhong, Xiaobo; Li, Linheng; Wang, Li Less
Hepatology. 66(4):1183-1196, October 2017.
TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling
Masyuk, Tatyana V.; Masyuk, Anatoliy I.; Lorenzo Pisarello, Maria; More
Masyuk, Tatyana V.; Masyuk, Anatoliy I.; Lorenzo Pisarello, Maria; Howard, Brynn N.; Huang, Bing Q.; Lee, Pui‐Yuen; Fung, Xavier; Sergienko, Eduard; Ardecky, Robert J.; Chung, Thomas D.Y.; Pinkerton, Anthony B.; LaRusso, Nicholas F. Less
Hepatology. 66(4):1197-1218, October 2017.
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta‐analysis
Albillos, Agustín; Zamora, Javier; Martínez, Javier; More
Albillos, Agustín; Zamora, Javier; Martínez, Javier; Arroyo, David; Ahmad, Irfan; De‐la‐Peña, Joaquin; Garcia‐Pagán, Juan‐Carlos; Lo, Gin‐Ho; Sarin, Shiv; Sharma, Barjesh; Abraldes, Juan G.; Bosch, Jaime; Garcia‐Tsao, Guadalupe; on behalf of the Baveno Cooperation Less
Hepatology. 66(4):1219-1231, October 2017.
Targeting CCl4‐induced liver fibrosis by RNA interference–mediated inhibition of cyclin E1 in mice
Bangen, Jörg‐Martin; Hammerich, Linda; Sonntag, Roland; More
Bangen, Jörg‐Martin; Hammerich, Linda; Sonntag, Roland; Baues, Maike; Haas, Ute; Lambertz, Daniela; Longerich, Thomas; Lammers, Twan; Tacke, Frank; Trautwein, Christian; Liedtke, Christian Less
Hepatology. 66(4):1242-1257, October 2017.
Loss of L‐selectin‐guided CD8+, but not CD4+, cells protects against ischemia reperfusion injury in a steatotic liver
Kolachala, Vasantha L.; Palle, Sirish; Shen, Ming; More
Kolachala, Vasantha L.; Palle, Sirish; Shen, Ming; Feng, Alayna; Shayakhmetov, Dmitry; Gupta, Nitika A. Less
Hepatology. 66(4):1258-1274, October 2017.
Death and liver transplantation within 2 years of onset of drug‐induced liver injury
Hayashi, Paul H.; Rockey, Don C.; Fontana, Robert J.; More
Hayashi, Paul H.; Rockey, Don C.; Fontana, Robert J.; Tillmann, Hans L.; Kaplowitz, Neil; Barnhart, Huiman X.; Gu, Jiezhan; Chalasani, Naga P.; Reddy, K. Rajender; Sherker, Averell H.; Hoofnagle, Jay H.; for the Drug‐Induced Liver Injury Network (DILIN) Investigators Less
Hepatology. 66(4):1275-1285, October 2017.
FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients
So‐Armah, Kaku A.; Lim, Joseph K.; Lo Re, Vincent; More
So‐Armah, Kaku A.; Lim, Joseph K.; Lo Re, Vincent; Tate, Janet P.; Chang, Chung‐Chou H.; Butt, Adeel A.; Gibert, Cynthia L.; Rimland, David; Marconi, Vincent C.; Goetz, Matthew B.; Rodriguez‐Barradas, Maria C.; Budoff, Matthew J.; Tindle, Hilary A.; Samet, Jeffrey H.; Justice, Amy C.; Freiberg, Matthew S.; for the Veterans Aging Cohort Study Project Team Less
Hepatology. 66(4):1286-1295, October 2017.
Consensus Statement
Concise Review
Acute hepatic porphyrias: Recommendations for evaluation and long‐term management
Balwani, Manisha; Wang, Bruce; Anderson, Karl E.; More
Balwani, Manisha; Wang, Bruce; Anderson, Karl E.; Bloomer, Joseph R.; Bissell, D. Montgomery; Bonkovsky, Herbert L.; Phillips, John D.; Desnick, Robert J.; for the Porphyrias Consortium of the Rare Diseases Clinical Research Network Less
Hepatology. 66(4):1314-1322, October 2017.
Review
Large‐scale computational models of liver metabolism: How far from the clinics?
Cvitanović, Tanja; Reichert, Matthias C.; Moškon, Miha; More
Cvitanović, Tanja; Reichert, Matthias C.; Moškon, Miha; Mraz, Miha; Lammert, Frank; Rozman, Damjana Less
Hepatology. 66(4):1323-1334, October 2017.
Hepatology Elsewhere
Clinical Observations in Hepatology
Direct‐acting antivirals during or after immunochemotherapy in hepatitis C virus–positive diffuse large B‐cell lymphomas
Merli, Michele; Frigeni, Marco; Gotti, Manuel; More
Merli, Michele; Frigeni, Marco; Gotti, Manuel; Grossi, Paolo; Bruno, Raffaele; Passamonti, Francesco; Arcaini, Luca Less
Hepatology. 66(4):1341-1343, October 2017.
Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature
Ono, Atsushi; Goossens, Nicolas; Finn, Richard S.; More
Ono, Atsushi; Goossens, Nicolas; Finn, Richard S.; Schmidt, Warren N.; Thung, Swan N.; Im, Gene Y.; Hoshida, Yujin; on behalf of Precision Liver Cancer Prevention Consortium Less
Hepatology. 66(4):1344-1346, October 2017.
Correspondence
Reply
Paul, Sonali
Paul, Sonali Less
Hepatology. 66(4):1354, October 2017.
Reply
Bajaj, Jasmohan S.; Kassam, Zain; Cox, I. Jane; More
Bajaj, Jasmohan S.; Kassam, Zain; Cox, I. Jane; Gurry, Thomas; Williams, Roger; Alm, Eric; John, Binu; Smith, Mark; Taylor‐Robinson, Simon D.; Gillevet, Patrick M. Less
Hepatology. 66(4):1355-1356, October 2017.
Reply
Singh, Siddharth; Loomba, Rohit
Singh, Siddharth; Loomba, Rohit Less
Hepatology. 66(4):1359-1360, October 2017.
Reply
Kalafateli, Maria; Tsochatzis, Emmanuel A.
Kalafateli, Maria; Tsochatzis, Emmanuel A. Less
Hepatology. 66(4):1361-1362, October 2017.